Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

641 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted therapy: the fast pace of progress.
Garrett C. Garrett C. Cancer Control. 2005 Apr;12(2):71-2. doi: 10.1177/107327480501200201. Cancer Control. 2005. PMID: 15855889 Free article. No abstract available.
Targeted therapies in the treatment of colorectal cancers.
Alekshun T, Garrett C. Alekshun T, et al. Among authors: garrett c. Cancer Control. 2005 Apr;12(2):105-10. doi: 10.1177/107327480501200205. Cancer Control. 2005. PMID: 15855893 Free article. Review.
Malignant pleural mesothelioma: a comprehensive review.
Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR. Ismail-Khan R, et al. Among authors: garrett cr. Cancer Control. 2006 Oct;13(4):255-63. doi: 10.1177/107327480601300402. Cancer Control. 2006. PMID: 17075562 Free article. Review.
Imaging gastrointestinal stromal tumors.
Hersh MR, Choi J, Garrett C, Clark R. Hersh MR, et al. Among authors: garrett c. Cancer Control. 2005 Apr;12(2):111-5. doi: 10.1177/107327480501200206. Cancer Control. 2005. PMID: 15855894 Free article.
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.
Liu X, George GC, Tsimberidou AM, Naing A, Wheler JJ, Kopetz S, Fu S, Piha-Paul SA, Eng C, Falchook GS, Janku F, Garrett C, Karp D, Kurzrock R, Zinner R, Raghav K, Subbiah V, Hess K, Meric-Bernstam F, Hong DS, Overman MJ. Liu X, et al. Among authors: garrett c. BMC Cancer. 2015 Oct 16;15:713. doi: 10.1186/s12885-015-1701-3. BMC Cancer. 2015. PMID: 26474549 Free PMC article.
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.
Garrett CR, Siu LL, El-Khoueiry A, Buter J, Rocha-Lima CM, Marshall J, LoRusso P, Major P, Chemidlin J, Mokliatchouk O, Velasquez L, Hayes W, Feltquate D, Syed S, Ford S, Kollia G, Galbraith S, Nuyten DS. Garrett CR, et al. Br J Cancer. 2011 Jun 28;105(1):44-52. doi: 10.1038/bjc.2011.182. Epub 2011 May 31. Br J Cancer. 2011. PMID: 21629245 Free PMC article. Clinical Trial.
641 results